Firms/companies
Hit by wage hike, CIL may hike coal prices
14 Mar 2012
UK trust warns Coal India of legal action
13 Mar 2012
ED launches scan of Antrix-Devas spectrum deal
13 Mar 2012
The ED’s Bangalore zone office has begun the probe to ascertain if any foreign exchange or anti-money laundering laws were contravened when the deal was signed
Azim Premji Trust to sell 1.4% Wipro stake; net Rs1,500 cr
13 Mar 2012
The trust plans to use the money raised through the sale of shares to improve the quality of school education
Pfizer terminates $350-mn insulin marketing deal with Biocon
13 Mar 2012
In a surprise move, US drug giant Pfizer Inc, today called off an insulin distribution agreement with Biocon to sell the Bangalore-based company’s biosimilar versions of the drug in key global markets including the US
Pfizer terminates $350-mn insulin marketing deal with Biocon
13 Mar 2012
In a surprise move, US drug giant Pfizer Inc, today called off an insulin distribution agreement with Biocon to sell the Bangalore-based company’s biosimilar versions of the drug in key global markets including the US
CNN in talks to buy technology news site Mashable for $200 mn: report
13 Mar 2012
If the CNN-Mashable deal goes through, it would be CNN’s biggest acquisition to date, since its acquisition of popular news reader app for Apple’s iPad, Zite in 2011.
CNN in talks to buy technology news site Mashable for $200 mn: report
13 Mar 2012
If the CNN-Mashable deal goes through, it would be CNN’s biggest acquisition to date, since its acquisition of popular news reader app for Apple’s iPad, Zite in 2011.
CNN in talks to buy technology news site Mashable for $200 mn: report
13 Mar 2012
If the CNN-Mashable deal goes through, it would be CNN’s biggest acquisition to date, since its acquisition of popular news reader app for Apple’s iPad, Zite in 2011.
Natco granted compulsory licence for Bayer's Nexavar
12 Mar 2012
The compulsory licence, the first of its kind to be granted in India, enables Natco to sell the drug at up to Rs8,880 for a pack of 120 tablets against Rs284,428 for Bayer's Nexavar
Natco granted compulsory licence for Bayer's Nexavar
12 Mar 2012
The compulsory licence, the first of its kind to be granted in India, enables Natco to sell the drug at up to Rs8,880 for a pack of 120 tablets against Rs284,428 for Bayer's Nexavar